Bupropion is effective in depression in narcolepsy

International Journal of Psychiatry in Clinical Practice

Volumn 9, Issue 4, 2005, Pages 289-291

  Goksan, Burcu ^a,b   Mercan, Sibel ^a   Karamustafalioglu, Oguz ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Bupropion; Depression; Narcolepsy; Narcolepsy cataplexy syndrome

Indexed keywords

AMFEBUTAMONE; IMIPRAMINE; MODAFINIL;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CASE REPORT; CATAPLEXY; DEPRESSION; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; NARCOLEPSY; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 27844552916     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651500500241454     Document Type: Article

References (15)

1. Shapiro, CM, editor. ABC of Sleep Disorders; BMJ Publishing Group; 1993.
2. Zeman A, Britton T, Douglas N, Hansen A, Hicks J, Howard R, et al. Narcolepsy and excessive daytime sleepiness. Br Med J 2004;329:724-8.
3. Diagnostic Classification Steering Committee; Thorpy MJ, Chairman. International classification of sleep disorders: Diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association; 1990.
4. Standard of Practice Committee, American Academy of Sleep Medicine. Practice parameters for the treatment of narcolepsy. Sleep 2001;24:385-91.
5. Sadock BJ, Sadock VA, editors. Kaplan and Sadock's comprehensive textbook of psychiatry. Philadelphia, PA: Lippincott Williams and Wilkins; 2000.
6. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy: All patients were DR2 positive. Tissue Antigens 1984;24:316-9.
7. Scammell T. The neurobiology, diagnosis and treatment of narcolepsy. Ann Neurol 2003;53:154-66.
8. Rye DB, Dihenia B, Bliwise DL. Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion. Depression Anxiety 1998;7:92-5.
9. Vignatelli L, D'Alessandro R, Mosconi, Ferini-Stramb L, Guidolin L, De Vincentiis A, Plazzi G. Health-related quality of life in Italian patients with narcolepsy: The SF-36 health survey. Sleep Med 2004;5:467-75.
10. Kales A, Saldotas C, Bixler E, Caldwell A, Cadieus R, Verrechio J. Narcolepsy-cataplexy. Psychosocial consequences and associated psychopathology. Arch Neurol 1982;39:169-71.
11. Reynolds CF, Christiansen CL, Taska LS, Coble PA, Kupfer DJ. Sleep in narcolepsy and depression-Does it all look alike? J Nerv Ment Dis 1983;171:290-5.
12. Eisensehr I, Linke R, Tatsch K, von Lindeiner H, Kharraz B, Gildehaus FJ, et al. Alteration of the striatal dopaminergic system in human narcolepsy. Neurology 2003;60:1817-9.
13. Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmocology of bupropion, a dual norepinepherine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004;6:159-66.
14. Baldessarini RJ. Drugs and the treatment of psychiatric disorders: Depression and anxietydisorders. In: Hardman JG, Limbird LE, editors. Goodman & Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill; 2001. p 447-83.
15. Ascher JA, Cole JO, Colin J-N, et al. Bupropion: A review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395-401.